Cedric O'Gorman - Jan 6, 2023 Form 4 Insider Report for RELMADA THERAPEUTICS, INC. (RLMD)

Role
Chief Medical Officer
Signature
/s/ Cedric O'Gorman
Stock symbol
RLMD
Transactions as of
Jan 6, 2023
Transactions value $
$0
Form type
4
Date filed
1/13/2023, 04:54 PM
Next filing
May 24, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RLMD Stock Option (right to buy) Award $0 -400K -50% $0.00 400K Jan 6, 2023 Common stock 400K $3.29 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares vest in 16 equal quarterly installments commencing on April 6, 2023.